ST. PAUL, Minn.--(BUSINESS WIRE)--On Wednesday, June 21, 2017, Cardiovascular Systems’ (NASDAQ: CSII) Chief Financial Officer, Larry Betterley, will present at the JMP Securities Life Sciences Conference at 11:30 a.m. Eastern Time.
You may access the live audio webcast and presentation materials in the events section of the company’s investor relations website, http://investors.csi360.com/Investors/Events.
About Cardiovascular Systems, Inc.
Cardiovascular
Systems, Inc., based in St. Paul, Minn., is a medical device company
focused on developing and commercializing innovative solutions for
treating vascular and coronary disease. The company’s Orbital
Atherectomy Systems treat calcified and fibrotic plaque in arterial
vessels throughout the leg and heart in a few minutes of treatment time,
and address many of the limitations associated with existing surgical,
catheter and pharmacological treatment alternatives. The U.S. FDA
granted the first 510(k) clearance for the use of the Orbital
Atherectomy System in peripheral arteries in August 2007. In October
2013, the company received FDA approval for the Coronary Orbital
Atherectomy System. To date, over 308,000 of CSI’s devices have been
sold to leading institutions across the United States. For more
information, visit the company’s website at www.csi360.com.